Your browser doesn't support javascript.
loading
Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival.
Nyman, Sofi Sennefelt; Ahlström, Håkan; Creusen, Angeliki Dimopoulou; Dahlgren, David; Hedeland, Mikael; Heindryckx, Femke; Johnson, Ulf; Khaled, Jaafar; Kullenberg, Fredrik; Nyman, Rickard; Rorsman, Fredrik; Sheikhi, Reza; Simonsson, Ulrika S H; Sjögren, Erik; Wanders, Alkwin; Lennernäs, Hans; Ebeling Barbier, Charlotte.
Afiliação
  • Nyman SS; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden sofi_nyman@hotmail.com.
  • Ahlström H; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden.
  • Creusen AD; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden.
  • Dahlgren D; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Hedeland M; Department of Medicinal Chemistry, Analytical Pharmaceutical Chemistry, Uppsala University, Uppsala, Sweden.
  • Heindryckx F; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Johnson U; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden.
  • Khaled J; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Kullenberg F; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Nyman R; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden.
  • Rorsman F; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Sheikhi R; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Simonsson USH; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Sjögren E; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Wanders A; Department of Pathology, Aalborg University Hospital, Aalborg, Denmark.
  • Lennernäs H; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Ebeling Barbier C; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
BMJ Open ; 12(11): e065839, 2022 11 07.
Article em En | MEDLINE | ID: mdl-36343995
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Guideline Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Guideline Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article